The effect of inhaled albuterol in moderate to severe asthma

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 2, 1996, Pages 295-301

  Apter, Andrea J ^a,b   Reisine, Susan T ^a   Willard, Alice ^b   Clive, Jonathan ^b   Wells, Meredith ^d   Metersky, Mark ^a   McNally, Daniel ^a   ZuWallack, Richard L ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^d NONE

Author keywords

albuterol; Asthma; compliance; peak expiratory flow rate; quality of life

Indexed keywords

PREDNISONE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029813283     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70153-7     Document Type: Article

References (9)

1. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-6.
2. Taylor DR, Sears MR, Herbison GP, et al. Regular inhaled β-agonist in asthma: effects on exacerbations and lung function. Thorax 1993;48:134-8.
3. Chapman KR, Kesten S, Szalai JP. Regular vs as-needed inhaled salbutamol in asthma control. Lancet 1994;343:1379-82.
4. Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1994;151:66-70.
5. National Asthma Education Panel. Guidelines for the diagnosis and management of asthma. Bethesda: NIH Publication No. 91-3042, 1991.
6. Juniper EF, Guyatt GH, Epstein RS. Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83.
7. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining the minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81-7.
8. Fleiss JL. The design and analysis of clinical experiments. New York: Wiley, 1986.
9. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992;146:1559-64.